ugt-47 Antibody

UGD-glucuronosyltransferases (UGTs) play critical roles in drug metabolism and cancer biology, with specific isoforms like UGT1A7 demonstrating unique enzymatic and non-enzymatic functions in disease progression. Below are research-focused FAQs addressing key methodological and analytical challenges related to UGT1A7 antibody applications, supported by experimental evidence from peer-reviewed studies.

What experimental designs address contradictory UGT1A7 expression data in colorectal vs. breast cancer models?

Advanced resolution strategy:

• Conduct cell-context CRISPR screens to identify co-regulated genes (e.g., nuclear receptors like PXR) that modulate UGT1A7 activity .

• Quantify SN-38 glucuronidation rates alongside antibody-based protein measurements to distinguish enzymatic vs. non-enzymatic roles .

How can I optimize Western blot protocols for UGT1A7 given its low abundance in extrahepatic tissues?

Technical recommendations:

• Use membrane fractionation to enrich microsomal proteins (UGT1A7 is ER-localized) .

• Load ≥50 µg of protein/lane and employ high-sensitivity chemiluminescent substrates.

• Validate with antibodies showing cross-reactivity across human, mouse, and rat models (e.g., Cell Signaling #4371) .

What advanced techniques resolve UGT1A7’s dual roles in drug resistance and cancer progression?

Integrated workflow:

• Metabolomic profiling: Compare ceramide and prostaglandin E2 levels in UGT1A7-high vs. low CLL cells .

• Crispr-Cas9 functional assays: Disrupt UGT1A7 in patient-derived xenografts to assess impacts on venetoclax sensitivity .

• Proximity ligation assays: Map UGT1A7 interactions with HSP90 or BCL-2 family proteins .

How do I interpret conflicting UGT1A7 prognostic data in chronic lymphocytic leukemia (CLL)?

Analytical framework:

• Stratify patients by IGHV mutation status: UGT1A7’s prognostic power is strongest in mutated subgroups .

• Measure circulating steroid levels, as UGT1A7’s non-enzymatic effects may dominate in low-androgen environments .

What controls are essential when studying UGT1A7 in multi-omics datasets?

Quality assurance steps:

• Include housekeeping genes (β-actin, GAPDH) with Ct values ≤25 in qPCR .

• For mass spectrometry, spike in stable isotope-labeled UGT1A7 peptides (e.g., VVLLSPFK with 13C/15N) .

• Cross-validate RNA-seq findings with Nanostring nCounter for isoforms (e.g., UGT1A7-201 vs. 202) .